General clinical and anthropometric parameters in patients with type 1 diabetes mellitus depending on the level of albumin in the urine

  • Yu. O. Kryvoviaz National Pirogov Memorial Medical University, Vinnytsya, Ukraine
Keywords: type 1 diabetes mellitus, albuminuria, angiopathy, retinopathy, neuropathy, general clinical indicators, anthropometric indicators.


Currently there are many experimental markers of diabetic nephropathy, but clinical practice focuses mainly on the presence of albuminuria, which usually manifests itself in both adults and children on average 5-7 years after the onset of diabetes. The aim of the study was to study the general clinical and anthropometric parameters in patients with type 1 diabetes mellitus (T1D) depending on the level of albumin in the urine. The study included 78 men and 62 women aged 22 to 26 years with T1D. The control group consisted of 8 healthy men and 13 healthy women of the same age. The level of microalbuminuria was determined in all patients by enzyme-linked immunosorbent assay. The assessment of general clinical (pulse, systolic, diastolic pressure) and anthropometric (height, weight, body surface area, waist circumference, body mass index) indicators was performed. Statistical processing of the obtained results was performed in the license package “Statistica 5.5”, using non-parametric evaluation methods. It was found that angio-, retino- and neuropathy occurred in all patients with T1D. Simultaneously with the increase in albuminuria, the percentage of patients with deeper degrees of these complications increased. It was found that with increasing levels of albumin in the urine in most cases increases the percentage of patients with a correspondingly severe degree of these complications. Thus, in patients with T1D men found: angiopathy of the III degree with normoalbuminuria – 12.5 %, with microalbuminuria – 40.0 %, with proteinuria – 53.8 %; retinopathy of the II-III degree with normoalbuminuria – 0 % and 7.5 %, with microalbuminuria – 4.0 % and 40.0 %, with proteinuria – 100 % and 0 %; II-III degree neuropathy with normoalbuminuria – 65.0 % and 0 %, with microalbuminuria – 92.0 % and 0 %, with proteinuria – 0 % and 92.3 %. In patients with T1D women were found: angiopathy of the III degree with normoalbuminuria – 29.0 %, with microalbuminuria – 13.0 %, with proteinuria – 62.5 %; retinopathy of the II-III degree with normoalbuminuria – 3.2 % and 9.7 %, with microalbuminuria – 4.3 % and 26.1 %, with proteinuria – 87.5 % and 0 %; II-III degree neuropathy with normoalbuminuria – 71.0 % and 0 %, with microalbuminuria – 91.3 % and 0 %, with proteinuria – 12.5 % and 75.0 %. In patients with T1D with normo-, microalbuminuria and proteinuria, the value of systolic, diastolic blood pressure and pulse, in most cases, significantly higher than in healthy subjects (respectively in men by 6.1-18.3 % – 3.6-20.3 % and 4.2-14.7 %; in women – by 5.0-20.0 % – 9.1-22.8 % and 8.0-31.6 %). The value of these indicators increased with the increase in the level of albumin in the urine (respectively in men by 11.4 % – 16.1 % and 10.1 %; in women –- by 13.3 % – 10.0 % and 21.8 %). Patients with T1D had lower values of growth (respectively in men by 4.6-9.2 %; in women – 2.2-4.1 %), weight (only in men by 9.0-26.4 %) and body surface area (respectively in men by 7.2-17.7 %, in women – 4.8 % only in the group of proteinuria). Body mass index in sick men, compared with healthy, was significantly lower only in the group of proteinuria (by 5.5 %); and in women it was higher in the groups of normo- and microalbuminuria (by 10.6 % and 11.2 %). Patients with T1D women compared to healthy women had a larger waist circumference (by 5.5-11.8 %), and in patients with T1D men – on the contrary, this figure was lower in the group of microalbuminuria (by 4.0 %). Thus, the differences in general clinical and anthropometric parameters between patients with T1D with different levels of albumin in the urine and the degree of complications from the vascular and nervous system allow to assess the severity and compensation of the disease, and comparison of these indicators with the control group possibilities of disease development and peculiarities of the pathological process.


[1] Abegaz, T. M., Abdela, O. A., Bhagavathula, A. S., & Teni, F. S. (2018). Magnitude and determinants of uncontrolled blood pressure among hypertensive patients in Ethiopia: hospital-based observational study. Pharmacy Practice (Granada), 16(2), 1173. doi: 10.18549/PharmPract.2018.02.1173
[2] Akoum, N., Zelnick, L. R., de Boer, I. H., Hirsch, I. B., Trence, D., Henry, C., ... & Bansal, N. (2019). Rates of cardiac rhythm abnormalities in patients with CKD and diabetes. Clinical Journal of the American Society of Nephrology, 14(4), 549-556. doi: 10.2215/CJN.09420818
[3] Chaplyhyna, E. V., & Vartanova, O. T. (2013). Особенности распределения жироотложения у лиц с сахарным диабетом [Features of the distribution of fat deposition in persons with diabetes mellitus]. В Проблемы современной морфологии человека – In Problems of modern human morphology (pp. 153-155).
[4] Chawla, A., Chawla, R., & Jaggi, S. (2016). Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum?. Indian journal of endocrinology and metabolism, 20(4), 546-551. doi: 10.4103/2230-8210.183480
[5] Dedov, I. I. (2012). Сахарный диабет: острые и хронические осложнения [Diabetes mellitus: acute and chronic complications]. Москва: МИА – Moscow: MIA.
[6] Galić, B. S., Pavlica, T., Udicki, M., Stokić, E., Mikalački, M., Korovljev, D., ... & Adamović, D. (2016). Somatotype characteristics of normal-weight and obese women among different metabolic subtypes. Archives of endocrinology and metabolism, 60(1), 60-65. doi: 10.1590/2359-3997000000159
[7] Grisanti, L. A. (2018). Diabetes and arrhythmias: pathophysiology, mechanisms and therapeutic outcomes. Frontiers in physiology, 9, 1669. doi: 10.3389/fphys.2018.01669
[8] Harding, J. L., Pavkov, M. E., Magliano, D. J., Shaw, J. E., & Gregg, E. W. (2019). Global trends in diabetes complications: a review of current evidence. Diabetologia, 62(1), 3-16. doi: 10.1007/s00125-018-4711-2
[9] Ilyas, Z., Chaiban, J. T., & Krikorian, A. (2017). Novel insights into the pathophysiology and clinical aspects of diabetic nephropathy. Reviews in Endocrine and Metabolic Disorders, 18(1), 21-28. doi: 10.1007/s11154-017-9422-3
[10] Karmakar, R. N., Khandakar, M. R., Gangopadhyay, P. K., Ghosh, K., & Babu, A. S. (2011). Albuminuria and neuropathy in newly detected diabetics: profile and correlation. Journal of the Indian Medical Association, 109(6), 396-399. PMID: 22315767
[11] Lee, S. Y., & Choi, M. E. (2015). Urinary biomarkers for early diabetic nephropathy: beyond albuminuria. Pediatric nephrology, 30(7), 1063-1075. doi: 10.1007/s00467-014-2888-2
[12] Lim, A. K. (2014). Diabetic nephropathy–complications and treatment. International journal of nephrology and renovascular disease, 7, 361-381. doi: 10.2147/IJNRD.S40172
[13] MacIsaac, R. J., Ekinci, E. I., & Jerums, G. (2014). Progressive diabetic nephropathy. How useful is microalbuminuria?: contra. Kidney International, 86(1), 50-57. doi: 10.1038/ki.2014.98
[14] Page-Reeves, J., Mishra, S. I., Niforatos, J., Regino, L., & Bulten, R. (2013). An integrated approach to diabetes prevention: anthropology, public health, and community engagement. Qualitative report (Online), 18, 1-22. PMID: 24490179
[15] Rawshani, A., Rawshani, A., Franzén, S., Eliasson, B., Svensson, A. M., Miftaraj, M., ... & Gudbjörnsdottir, S. (2017). Mortality and cardiovascular disease in type 1 and type 2 diabetes. New England journal of medicine, 376(15), 1407-1418. doi: 10.1056/NEJMoa1608664
[16] Rawshani, A., Sattar, N., Franzén, S., Rawshani, A., Hattersley, A. T., Svensson, A. M., ... & Gudbjörnsdottir, S. (2018). Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study. The Lancet, 392(10146), 477-486. doi: 10.1016/S0140-6736(18)31506-X
[17] Sampanis, C., & Zamboulis, C. (2008). Arterial hypertension in diabetes mellitus: from theory to clinical practice. Hippokratia, 12(2), 74-80. PMID: 18923653
[18] Sénéchal, M., McGavock, J. M., Church, T. S., Lee, D. C., Earnest, C. P., Sui, X., & Blair, S. N. (2014). Cut-points of muscle strength associated with metabolic syndrome in men. Medicine and science in sports and exercise, 46(8), 1475-1481. doi: 10.1249/MSS.0000000000000266
[19] Senko, V. I., Okolokulak, E. S., & Sydorovych, S. A. (2009). Особенности типа телосложения у лиц, страдающих сахарным диабетом первого типа [Features of the body type in persons with type 1 diabetes mellitus]. Проблемы здоровья и экологии – Health and environmental issues, (2 (20)), 12-17.
[20] Shtanko, V. A., Tykhonova, S. A., Marish, M. Yu., & Tesliuk, G. B. (2015). Роль соматотипу та вегетативної дисрегуляції у клінічному перебігу артеріальної гіпертензії [The role of somatotype and autonomic dysregulation in the clinical course of hypertension]. Досягнення біології та медицини – Advances in biology and medicine, (1), 56-59.
[21] Sokolov, V. V., & Berberian, O. T. (2002). Содержание основных масс тела у лиц, страдающих сахарным диабетом [The content of the main body weights in persons with diabetes mellitus]. Материалы IV международного конгресса по интегративной антропологи: Сб. тезисов. – СПб.: Издательство СПБГМУ – Materials of the IV International Congress on Integrative Anthropology: Collection of Abstracts. – SPb.: Publishing house of SPbGMU, 340-341.
[22] Solovjeva, A. V., Sysoeva, M. S., Lapkyn, M. M., & Rakyta, D. R. (2012). Анализ состава тела и уровня основного обмена у лиц с различным индексом массы тела [Analysis of body composition and basal metabolic rate in individuals with different body mass index]. Доктор. Ру – Doctor. Ru, (7), 86-89.
[23] Veselovska, N. N. (2013). Чинники ризику судинной патології органа зору у хворих на цукровий діабет [Risk factors for vascular pathology of the visual organ in patients with diabetes mellitus]. Клінічна ендокринологія та ендокринна хірургія – Clinical endocrinology and endocrine surgery, (1), 42-46.
[24] Viazzi, F., Leoncini, G., & Pontremoli, R. (2013). Global cardiovascular risk assessment in the management of primary hypertension: the role of the kidney. International journal of hypertension, 2013. doi: 10.1155/2013/542646
[25] Weiss, J. S., & Sumpio, B. E. (2006). Review of prevalence and outcome of vascular disease in patients with diabetes mellitus. European Journal of Vascular and Endovascular Surgery, 31(2), 143-150. doi: 10.1016/j.ejvs.2005.08.015
[26] White, J. R. (2012). Angiotensin receptor blocker to prevent microalbuminuria?. Clinical Diabetes, 30(1), 20-22. doi: 10.2337/diaclin.30.1.20
[27] Zhmuryk, V. V., Kukhar, I. D., & Zhmuryk, D. V. (2007). Особливості антропометричних показників та соматотипу у дорослого населення, хворого на інсулінозалежний цукровий діабет [Features of anthropometric parameters and somatotype in the adult population with insulin-dependent diabetes mellitus]. Вісник морфології – Reports of Morphology, 1(13), 157-162.
How to Cite
Kryvoviaz, Y. O. (2020). General clinical and anthropometric parameters in patients with type 1 diabetes mellitus depending on the level of albumin in the urine. Biomedical and Biosocial Anthropology, (38), 61-68.